Signaling Mechanism of the DNA Replication Checkpoint
Signaling Mechanism of the DNA Replication Checkpoint
批准号:
9695226
负责人:
Yongjie Xu
金额:
$25.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-01 至 2022-01-31
关键词:
AddressBindingBiochemical GeneticsBiological ModelsCell CycleCell DeathCell SurvivalClinicalCytokinesisDNA DamageDNA biosynthesisDNA replication forkDNA-Directed DNA PolymeraseDataDefectEndogenous FactorsEnzymesEukaryotaExogenous FactorsFission YeastGeneticGenetic ScreeningGenome StabilityGenomic InstabilityGoalsHumanIn VitroIndividualKnowledgeLinkMalignant NeoplasmsMapsMethodsMissionModelingMolecularMutationOutcomePathway interactionsPharmaceutical PreparationsPhosphorylationPhosphorylation SitePlayProteinsPublic HealthPublicationsPublishingResearchRestRibonucleotide Reductase InhibitorRoleSeriesSignal PathwaySignal TransductionSterolsStressSurveysSystemTestingTherapeuticUnited States National Institutes of HealthWorkYeastsbasecell killingdisabilitygenetic approachgenome integrityhelicasehydroxyureain vivoinnovationinsightmutantnovelpublic health relevancereplication stressresponsesensortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Project Summary DNA replication checkpoint is a highly conserved signaling pathway in all eukaryotes. It plays a critical role in maintaining the DNA synthesis function of perturbed replication forks under stress. Perturbed forks, if undetected by the checkpoint, undergo catastrophic collapse resulting in chromosomal DNA damage or even cell death. Defects in the pathway are linked to genome instability and cancer. However, despite its importance and intense research efforts, our understanding of the mechanisms involved in the initiation of checkpoint signaling at the pertubed forks, fork stabilization, and cell survival remains incomplete. The long-term goal of our research is to understand the molecular interactions between the replication machinery and the checkpoint pathways for proper checkpoint signaling and fork protection by using S. pombe as the model system. The objective here is to define the important checkpoint functions of DNA polymerase Pol �, the replicative helicase CMG, and the sterol synthesis enzyme Erg11 (Cyp51 in humans). Our central hypotheses are (1) that the activated replication checkpoint targets Pol � and CMG on the leading strand to suppress the fork progression under stress and hence protect the perturbed forks against catastrophic collapse, and (2) that Erg11 may function as a new sensor of the stress induced by the ribonucleotide reductase inhibitor hydroxyurea. Our hypotheses are the results of our strong preliminary data and recent publications. The rationale for the proposed research is that understanding the checkpoint functions of these essential enzymes will provide novel insights into how the replication checkpoint signaling is initiated and how perturbed forks are stabilized for cell survival, the two most prominent questions in the field. Guided by strong preliminary data, these hypotheses will be tested by pursuing three specific aims: (1) determine how Pol � is regulated by the checkpoint for stabilization of perturbed forks; (2) discover the major target() of the replication checkpoint for cell survival under stress; and (3) define the functions of Erg11
in checkpoint signaling and hydroxyurea-induced cytokinesis arrest. Under the first two aims, we will conduct in vitro and in vivo studies to investigate how the activties of Pol � and CMG are regulated by the chekcpoint for fork protection and cell survival. We will also systematically analyze all replication proteins in fission yeast in order to identify the major checkpoint target() that may work alone or redundantly with the known targets. Under the third aim, the newly identified functions of Erg11 in checkpoint signaling and cytokinesis will be characterized. The approach is innovative, because it aims to provide a comprehensive molecular mechanism for checkpoint signaling in a model system representative of higher eukaryotes. The proposal is significant, because it is expected to vertically advance and expand our understanding of how checkpoint signaling is generated at perturbed forks and how perturbed forks are protected. Ultimately, such knowledge will advance our understanding of how genomic integrity is maintained and how it can be disrupted in all eukaryotes.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Inner nuclear membrane protein Lem2 facilitates Rad3-mediated checkpoint signaling under replication stress induced by nucleotide depletion in fission yeast.
在裂殖酵母中核苷酸耗尽诱导的复制应激下,内核膜蛋白 Lem2 促进 Rad3 介导的检查点信号传导。
DOI:
10.1016/j.cellsig.2015.12.009
发表时间:
2016
期刊:
Cellular signalling
影响因子:
4.8
作者:
[Xu,Yong-Jie]
通讯作者:
Xu,Yong-Jie
DOI:
10.3390/genes7110099
发表时间:
2016-11-17
期刊:
Genes
影响因子:
3.5
作者:
[Singh A, Xu YJ]
通讯作者:
Xu YJ
Novel Cell-Killing Mechanisms of Hydroxyurea and the Implication toward Combination Therapy for the Treatment of Fungal Infections.
羟基脲的新型细胞杀伤机制及其对治疗真菌感染的联合疗法的意义。
DOI:
10.1128/aac.00734-17
发表时间:
2017
期刊:
Antimicrobial agents and chemotherapy
影响因子:
4.9
作者:
[Singh,Amanpreet, Agarwal,Ameeta, Xu,Yong-Jie]
通讯作者:
Xu,Yong-Jie
DNA Replication Checkpoint in Fission Yeast
-
批准号:10331349
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2022
-
负责人:Yongjie Xu
-
依托单位:
DNA Replication Checkpoint in Fission Yeast
-
批准号:10557924
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2022
-
负责人:Yongjie Xu
-
依托单位:
Signaling Mechanism of the DNA Replication Checkpoint
-
批准号:9001349
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2015
-
负责人:Yongjie Xu
-
依托单位:
Signaling Mechanism of the DNA Replication Checkpoint
-
批准号:8818250
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2015
-
负责人:Yongjie Xu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: